
handle: 11499/7653 , 11499/42746
Results: Out of 100 patients who presenting to quit smoking, 76 (76.0%) were male and 24 (24.0%) were female. Fifteen patients who presenting to quit Maras powder use were all male. The mean age of the participants was 62.98±4.30 years (min=60, max=81) and did not differ between the female and male participants (p=0.351). Forty-eight smokers (48.0%) gave up smoking during treatment, but 52 smokers (52.0%) were still smoking during treatment. Eight Maras powder users stopped using the powder after treatment, but seven Maras powder users continued using Maras powder despite treatment.
Conclusion: We found that a high proportion of patients aged 60 years or older stopped using tobacco after treatment. Determination to stop tobacco use, appropriate treatment and regular follow-up play an important part in quitting tobacco use. © 2014, Geriatrics Society. All rights reserved.
Introduction: The aim of this study was to investigate the effectiveness of treatment for quitting smoking and Maras powder use in patients aged 60 years or older, and to examine factors likely to be effective in stopping tobacco use.
Materials and Method: Out of 178 patients aged 60 years or older, who presented to our outpatient clinic for quitting smoking and Maras powder use, 115 for whom there were no missing data were enrolled in this study.
retrospective study, Tobacco smokeless, 610, morbidity, Smoking cessation, medical record, geriatric patient, Article, smoking, nicotine replacement therapy, six point scale, male, medicinal plant, Smoke, behavior therapy, follow up, named inventories, human, Maras powder, Cerrahi, drug use, named inventories, questionnaires and rating scales, amfebutamone, adult, interview, outpatient department, smokeless tobacco, questionnaires and rating scales, major clinical study, mortality, Nicotiana rustica linn, smoking cessation, varenicline, aged, female
retrospective study, Tobacco smokeless, 610, morbidity, Smoking cessation, medical record, geriatric patient, Article, smoking, nicotine replacement therapy, six point scale, male, medicinal plant, Smoke, behavior therapy, follow up, named inventories, human, Maras powder, Cerrahi, drug use, named inventories, questionnaires and rating scales, amfebutamone, adult, interview, outpatient department, smokeless tobacco, questionnaires and rating scales, major clinical study, mortality, Nicotiana rustica linn, smoking cessation, varenicline, aged, female
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
